Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Drug resistant HIV.

Hatano H, Deeks SG.

BMJ. 2007 Jun 2;334(7604):1124-5. No abstract available.

2.

Report from the XVI International HIV Drug Resistance Workshop.

Kuritzkes DR.

AIDS Clin Care. 2007 Aug;19(8):69-70. No abstract available.

PMID:
17695089
3.

Is resistance to dolutegravir possible when this drug is used in first-line therapy?

Mesplède T, Wainberg MA.

Viruses. 2014 Aug 27;6(9):3377-85. doi: 10.3390/v6093377. Review.

4.

HIV treatment and the nonclinician: getting your bearings.

[No authors listed]

HRSA Careaction. 2007 Jan:1-12. No abstract available.

PMID:
17380596
5.

Researchers buoyed by novel HIV drugs: will expand drug arsenal against resistant virus.

Stephenson J.

JAMA. 2007 Apr 11;297(14):1535-6. No abstract available.

PMID:
17426263
6.

[Integrase inhibition].

Bogner JR.

MMW Fortschr Med. 2009 Apr 30;151(18):68-71. German. No abstract available.

PMID:
19769082
7.

Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Advances in antiretroviral therapy.

Wilkin TJ, Taylor B, Olender S, Hammer SM.

Top HIV Med. 2008 Apr-May;16(1):31-60.

8.

[Raltegravir as first integrase inhibitor in an HIV-infection].

Papendorp SG, Brinkman K.

Ned Tijdschr Geneeskd. 2009 Jan 31;153(5):166-7. Dutch. No abstract available.

PMID:
19256240
9.

[New drugs--hope for salvage patients?].

Arastéh K, Müller M.

MMW Fortschr Med. 2005 Apr 25;147 Spec No 1:38-41. German.

PMID:
16385871
10.

International AIDS Conference: Toronto.

[No authors listed]

Proj Inf Perspect. 2006 Oct;(42):4-11. No abstract available.

PMID:
17162805
11.

Successful integrase inhibitor-based highly active antiretroviral therapy for a multidrug-class-resistant HIV type 1 group O-infected patient in Cameroon.

Aghokeng AF, Kouanfack C, Peeters M, Mpoudi-Ngole E, Delaporte E.

AIDS Res Hum Retroviruses. 2013 Jan;29(1):1-3. doi: 10.1089/AID.2012.0196. Epub 2012 Sep 11. No abstract available.

PMID:
22889147
12.

Report from the 13th retrovirus conference. New data on TMC114 and TMC125.

Hicks CB.

AIDS Clin Care. 2006 Apr;18(4):34. No abstract available.

PMID:
16718876
13.

Is there a role for etravirine in patients with Nonnucleoside reverse transcriptase inhibitor resistance?

Scott C, Grover D, Nelson M.

AIDS. 2008 May 11;22(8):989-90. doi: 10.1097/QAD.0b013e3282fa75df. Erratum in: AIDS. 2008 Sep 12;22(14):i.

PMID:
18453859
14.

Researchers explore new anti-HIV agents.

Stephenson J.

JAMA. 2002 Apr 3;287(13):1635-7. No abstract available.

PMID:
11926873
15.

Antiviral characteristics of GSK1265744, an HIV integrase inhibitor dosed orally or by long-acting injection.

Yoshinaga T, Kobayashi M, Seki T, Miki S, Wakasa-Morimoto C, Suyama-Kagitani A, Kawauchi-Miki S, Taishi T, Kawasuji T, Johns BA, Underwood MR, Garvey EP, Sato A, Fujiwara T.

Antimicrob Agents Chemother. 2015 Jan;59(1):397-406. doi: 10.1128/AAC.03909-14. Epub 2014 Nov 3.

16.

Integrase strand transfer inhibitors in the management of HIV-positive individuals.

Mesplède T, Quashie PK, Zanichelli V, Wainberg MA.

Ann Med. 2014 May;46(3):123-9. doi: 10.3109/07853890.2014.883169. Epub 2014 Mar 3. Review.

PMID:
24579911
17.

HIV type 1 integrase inhibitors: from basic research to clinical implications.

Jegede O, Babu J, Di Santo R, McColl DJ, Weber J, Quiñones-Mateu M.

AIDS Rev. 2008 Jul-Sep;10(3):172-89. Review.

PMID:
18820719
18.

HIV integrase inhibitors--out of the pipeline and into the clinic.

Havlir DV.

N Engl J Med. 2008 Jul 24;359(4):416-8. doi: 10.1056/NEJMe0804289. No abstract available.

19.

Evolution of a novel pathway leading to dolutegravir resistance in a patient harbouring N155H and multiclass drug resistance.

Hardy I, Brenner B, Quashie P, Thomas R, Petropoulos C, Huang W, Moisi D, Wainberg MA, Roger M.

J Antimicrob Chemother. 2015 Feb;70(2):405-11. doi: 10.1093/jac/dku387. Epub 2014 Oct 3.

PMID:
25281399
20.

Resistance to HIV integrase inhibitors.

Winslow DL.

AIDS Alert. 2011 Sep;26(9):106-7. No abstract available.

PMID:
22003537

Supplemental Content

Support Center